Biomarkers
ELN
In an analysis examining the association of genetic abnormalities defined in the 2017 ELN stratification criteria [Whole exome-sequencing (WES) was performed centrally with bone marrow aspirate samples collected at screening for 308 and 267 patients in the intensive and non-intensive studies, respectively. Mutations in the ELN risk stratification [